Abstract
I conducted a detailed examination of the prescription rates of antiallergic agents, including oral and nasal preparations, prescribed for patients with Japanese cedar pollinosis in 2016, when there was little cedar pollen in the air, and in 2019, when the atmospheric levels of cedar pollen were much higher.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
